Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.

Blog

Jan 15, 2015

5 Lessons From FDA's First Biosimilar Review

Lisa Mueller, partner in Michael Best's Intellectual Property and Chair of the Life Sciences and Chemical Practice Groups and Laura Opperman, Ph.D., a Patent Scientist in the Intellectual Property Practice group, gave input for a Law360 article titled, “5 Lessons From FDA’s First Biosimilar Review – Law360,” on January 8, 2015. To view the full article, click […]
back to top